Filing Flows › Comparisons › NVS vs SNY
Novartis AG vs Sanofi: NVS and SNY compared
Novartis AG is the larger company: $14.4B of revenue in its latest quarter (Q2 2026) against $11.6B for Sanofi (Q2 2026). Sanofi is growing faster (+16% against +2% a year earlier). Novartis AG is more profitable, with an operating margin of 33.0% against 9.0%.
Where the money goes: NVS and SNY
Novartis AG (NVS) · Q2 2026
Novartis AG, Q2 2026: revenue $14.4B (+2% year over year), operating margin 33.0%, net earnings $3.3B, operating cash flow $5.9B. The chart follows the revenue to costs, profit and cash.
Sanofi (SNY) · Q2 2026
Sanofi, Q2 2026: revenue $11.6B (+16% year over year), operating margin 9.0%, net earnings $377M. The chart follows the revenue to costs, profit and cash.
| Novartis AG (NVS) | Sanofi (SNY) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $14.4B | $11.6B |
| Revenue growth, Y/Y | +2% | +16% |
| Operating margin | 33.0% | 9.0% |
| Net earnings | $3.3B | $377M |
| Net margin | 22.6% | 3.3% |
| Operating cash flow | $5.9B | — |
Questions
Which is bigger, Novartis AG or Sanofi?
Novartis AG is the larger company: $14.4B of revenue in its latest quarter (Q2 2026) against $11.6B for Sanofi (Q2 2026).
Is Novartis AG or Sanofi growing faster?
Sanofi is growing faster (+16% against +2% a year earlier).
Which is more profitable, Novartis AG or Sanofi?
Novartis AG is more profitable, with an operating margin of 33.0% against 9.0%.
More: Novartis AG earnings · how Novartis AG makes money · Sanofi earnings · how Sanofi makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Jul 21, 2026; 6-K filed Jul 30, 2026). Fiscal quarters can end on different dates. Not investment advice.